Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0295566 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Weida Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Cardiology, Yizheng Hospital of Nanjing Drum Tower Hospital Group, Yizheng, Jiangsu, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Nantong City.
Abstract (Originalsprache)
Background
The purpose of this research was to verify that vericiguat, a soluble guanylate cyclase (sGC) stimulator, reduces myocardial ischemic reperfusion injury (MIRI), and to learn how this reduction happens. Methods and results To develop an ischaemia/reperfusion (I/R) model, the left anterior descending artery was blocked in minipigs under anesthesia for 90 minutes, followed by 180 minutes of reperfusion. Vericiguat is administered three hours before surgery. Two weeks after receiving therapy, pigs underwent cardiovascular magnetic resonance imaging (MRI) to evaluate the results. The MRI results suggest improvement in the myocardial infarct after vericiguat treatment. Vericiguat treatment for two weeks enhanced vascularity, inhibited pro-inflammatory cells, and decreased collagen deposition in the infarct zone of pigs. Short-term experiments investigating possible explanations have indicated that vericiguat has antiapoptotic effects on cardiomyocytes and increases levels of autophagy.
Conclusions
Vericiguat, an SGC activator, reduces MIRI in pigs by boosting autophagy, preventing apoptosis, and promoting angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Department of Cardiology, Yizheng Hospital of Nanjing Drum Tower Hospital Group, Yizheng, Jiangsu, China.
- The Department of Cardiology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
- Department of Cardiovascular Medicine, Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, Jiangsu, China.
ORCID-Profile: Wenbing Liu
Förderung
- Science and Technology Project of Nantong City
Zitieren
APA
Zhu, W., Ben, Y., Shen, Y., & Liu, W. (2023). Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion. PLOS ONE. https://doi.org/10.1371/journal.pone.0295566
Vancouver
Zhu W, Ben Y, Shen Y, Liu W. Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion. PLOS ONE. 2023. doi:10.1371/journal.pone.0295566
BibTeX
@article{Zhu2023,
author = {Zhu, Weida and Ben, Yue and Shen, Yang and Liu, Wenbing},
title = {Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0295566}
}
EUVIMED